A low anti-Müllerian hormone (AMH) level means your ovaries have a smaller pool of remaining eggs than average for your age. AMH below 1.0 ng/mL is generally considered low, and levels below 0.5 ng/mL indicate a significantly diminished reserve. This doesn’t necessarily mean you can’t get pregnant, but it does change the timeline and strategy for conception, and it may signal that menopause will arrive earlier than expected.
What AMH Actually Measures
AMH is produced by the small, developing follicles in your ovaries. Each follicle contains an immature egg, and the hormone they release acts as a brake on the rest of your egg supply, preventing too many dormant eggs from activating at once. When AMH is low, that braking signal weakens, and dormant eggs get recruited faster, which accelerates the depletion of your overall reserve.
This is why AMH is considered the best available marker of ovarian reserve. It reflects how many eggs are still in the pipeline waiting to mature over the coming months and years. Critically, it measures quantity, not quality. The genetic health of your eggs is tied much more closely to your age. A 30-year-old with low AMH still tends to have better egg quality than a 40-year-old with normal AMH, because chromosomal abnormalities in eggs rise with age due to accumulated damage to cellular energy systems and errors in chromosome separation during cell division.
Why You Might Not Notice Any Symptoms
Low AMH rarely announces itself with obvious signs. In a study of young women with significantly diminished ovarian reserve, 88% reported no menstrual irregularity at all, including those with AMH below 0.5 ng/mL. Their periods came on schedule and looked completely normal.
The one subtle clue: shorter menstrual cycles. Women with AMH at or below 1.1 ng/mL had cycles averaging about 25 days, compared to 31 days in women with normal AMH. About 60% of those with diminished reserve noticed their cycles had been getting shorter over the previous year, versus only 4% of women with normal reserve. This shortening happens before any other menstrual changes appear, making it the earliest detectable sign that your egg supply is declining faster than expected. If your cycles have crept from 30 days down to 25 or 26, that shift is worth mentioning to your doctor.
What Low AMH Means for Getting Pregnant
Low AMH makes conception harder, but the picture is more nuanced than a single number suggests. In women under 35 trying to conceive naturally, those with very low AMH (below the 5th percentile) took roughly twice as long to get pregnant compared to women with normal levels: about 13 months versus 7 months on average. The cumulative live birth rate over 18 months was also lower in the very low group (20% versus 56%), though this difference was only marginally statistically significant given the small sample size.
Age plays an enormous role in interpreting these numbers. A study of women under 30 found that the natural pregnancy rate was diminished with low AMH primarily at later reproductive ages, not necessarily in younger women. Your AMH gives you information about how much time you have, while your age tells you more about the odds for each individual cycle.
IVF With Low AMH
If you pursue IVF with low AMH, the most predictable difference is fewer eggs per retrieval cycle. Women under 30 with AMH below 1.0 ng/mL averaged about 3 eggs per retrieval, compared to nearly 12 eggs for women the same age with normal AMH. That’s a significant gap, and it often means more retrieval cycles to accumulate enough embryos.
The encouraging finding: cumulative live birth rates for younger women with low AMH were comparable to those with normal AMH (39% versus 50%, with no statistically significant difference). The women who succeeded typically went through more retrieval cycles (about 3.5 rounds versus 2 for those who didn’t achieve a live birth) and had a much higher rate of reaching the blastocyst stage, the more advanced embryo stage that correlates with better implantation. In other words, fewer eggs doesn’t mean no good eggs. It means you may need more attempts to find them.
The Connection to Early Menopause
One of the most important implications of low AMH is its link to premature ovarian insufficiency (POI), the medical term for ovarian function declining before age 40. AMH is the strongest predictor of this condition, outperforming other hormone tests.
The relationship isn’t a smooth, gradual slope. The risk of POI stays relatively stable as AMH declines, then jumps sharply once levels drop below 0.5 ng/mL. At that threshold, the odds of developing POI are roughly 66 times higher than in women with normal AMH. Levels between 0.5 and 1.1 ng/mL carry a moderately elevated risk, about 5 times higher than normal. This doesn’t mean early menopause is inevitable, but it does mean the window of fertility may be shorter than average, which affects decisions about family planning timelines.
Factors That Can Skew Your Results
Before assuming the worst, it’s worth knowing that certain factors can make AMH appear lower than your true reserve.
Hormonal birth control has been a source of confusion. Some studies have reported AMH levels about 30% lower in women using hormonal contraceptives, though others found no significant difference. One study of 105 long-term contraceptive users found median AMH of 2.89 ng/mL versus 3.37 ng/mL in non-users, a gap that wasn’t statistically meaningful. If you were tested while on hormonal contraception and got a borderline result, retesting a few months after stopping may give a clearer picture.
Vitamin D status adds another layer of complexity. In women with regular ovulation who don’t have PCOS, vitamin D supplementation has been shown to increase AMH levels. The relationship is complicated enough that researchers haven’t established a simple correction factor, but if you’re vitamin D deficient, addressing that deficiency could modestly shift your AMH reading upward. Cross-sectional studies looking at vitamin D and AMH levels at a single point in time have produced mixed results, so the clinical significance of this connection is still being sorted out.
Supplements That May Help Ovarian Response
For women with low AMH preparing for IVF, two supplements have the most clinical evidence behind them: CoQ10 and DHEA. A network meta-analysis of 16 randomized controlled trials involving over 2,300 women with poor ovarian response found that both offered meaningful benefits.
CoQ10 more than doubled the odds of a live birth compared to standard treatment alone, and it also increased the number of eggs retrieved. CoQ10 supports the cellular energy production that eggs depend on heavily, which is one reason it ranked highest for live birth improvement. DHEA, a hormone precursor, nearly tripled the embryo implantation rate and doubled the rate of high-quality embryos, along with increasing the average number of eggs retrieved by about 1.6 per cycle. These aren’t miracle fixes, but for women facing poor ovarian response, they represent some of the best-supported adjunct options available.
Neither supplement can reverse a declining ovarian reserve or raise AMH to normal levels. What they appear to do is help the eggs you do have develop more effectively, improving the odds that each retrieval cycle produces a viable embryo.
What the Number Doesn’t Tell You
AMH is a powerful tool, but it has real limitations. It cannot tell you whether you’ll get pregnant. It cannot tell you the chromosomal health of your remaining eggs. And a single low reading doesn’t account for natural fluctuations or testing conditions. What it does tell you is the size of your remaining egg pool, which is most useful as a planning tool: how urgently to pursue conception, whether to consider egg freezing, and what to expect from fertility treatment. The number matters most when combined with your age, your goals, and the full clinical picture.